While dual pharmacological inhibition of MCT1 and MCT4 appears feasible in vitro with syrosingopine, the concentrations required to observe cytotoxicity are high in the 2–5 micromolar range for primary CD138 + MM cells and 10–15 micromolar range for the HMCLs. This evidence concerns the gene SLC16A1 and Miyoshi myopathy.